First Affiliated Hospital of Shantou University Medical College
24
7
7
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
4.2%
1 terminated/withdrawn out of 24 trials
83.3%
-3.2% vs industry average
17%
4 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
Prospective Pathology Foundation Models
Role: collaborator
Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam
Role: collaborator
VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction
Role: lead
Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study
Role: collaborator
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III
Role: collaborator
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
Role: collaborator
Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion
Role: lead
TEER for Severe DMR of Low to Intermediate Surgery Risk
Role: collaborator
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
Role: collaborator
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Role: collaborator
Birth Weight-discordance in Twins Pregnancy: a Multicenter Retrospective Study
Role: collaborator
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer
Role: lead
South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol
Role: collaborator
Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
Role: collaborator
The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer
Role: collaborator
A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer
Role: collaborator
Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure
Role: collaborator
Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study
Role: collaborator
Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy
Role: collaborator
Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease
Role: collaborator